For instance, Mochi Health works with pharmacies that offer more affordable pricing on compounded semaglutide and tirzepatide
FDA approval is projected between Q3 2026 and Q1 2027, with Health Canada likely following within 6 to 12 months after that
Supplier pricing, vial sizes, and purity all affect cost
J Am Soc Nephrol 2021;32:2352-61.ArticlePubMedPMC 58
Liraglutide, another GLP-1 receptor agonist with a longer track record than semaglutide, has not generated significant reports of b12 deficiency in clinical practice
This might be a healthcare provider, a registered dietitian, a therapist who specializes in eating behavior, or a peer community of others navigating the same transition